Cybin Shares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cybin shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cybin Shares Today - Breaking & Trending Today

Cybin : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K -September 14, 2023 at 03:02 pm EDT

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

AND

MANAGEMENT INFORMATION CIRCULAR

. ....

British Columbia , United Kingdom , District Of Columbia , United States , Province Of British Columbia , Province Of Ontario , New York , Eric Hoskins , Pharma Optionholders , Pharma Securityholders , Gabriel Fahel , Mark Lawson , Pharma Optionholder , Cybin Sars , Cybin Privateco , Aaron Bartlone , Paul Glavine , George Tziras , Doug Drysdale , Theresa Firestone , Cybin Rsus , Greg Cavers , Pharma Securityholder , European Union , Program Under Cybin , Shoppers Drug Mart ,

BioPharma Stock News - Cybin (NYSE American: CYBN) (NEO: CYBN) to Acquire Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF)

BioPharma Stock News - Cybin (NYSE American: CYBN) (NEO: CYBN) to Acquire Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) ....

United States , City Of , United Kingdom , George Tziras , Gabriel Fahel , Jenny Maguire , Doug Drysdale , European Medicines Agency , Jefferies International , Aird Berlis , Newswire Cybin Inc , Health Canada , Head Of External Affairs , Cybin Inc , Supreme Court , Drug Administration , Exchange Commission , Venture Exchange , Small Pharma Special Committee , Neither The Neo Exchange Inc , Newsfile Corp Investorideas , Regulatory Agency , Small Pharma Inc , Newsfile Corp , Small Pharma , Small Pharma Share ,

Cybin Inc.: Cybin to Acquire Small Pharma Inc.

Cybin Inc.: Cybin to Acquire Small Pharma Inc.
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , United States , George Tziras , Gabriel Fahel , Jenny Maguire , Doug Drysdale , Small Pharma Inc , Jefferies International , Supreme Court , Head Of External Affairs , European Medicines Agency , Regulatory Agency , Venture Exchange , Health Canada , United Newsfile Corp , Neither The Neo Exchange Inc , Cybin Inc , Small Pharma Special Committee , Exchange Commission , Aird Berlis , Drug Administration , Small Pharma , Small Pharma Share , Cybin Shares , Cboe Canada ,

Cybin Inc.: Cybin to Acquire Small Pharma Inc.

Cybin Inc.: Cybin to Acquire Small Pharma Inc.
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Jenny Maguire , George Tziras , Gabriel Fahel , Doug Drysdale , Small Pharma Special Committee , Jefferies International , Cybin Inc , Neither The Neo Exchange Inc , Health Canada , Small Pharma Inc , European Medicines Agency , Drug Administration , Aird Berlis , Supreme Court , Exchange Commission , Venture Exchange , Head Of External Affairs , Regulatory Agency , Small Pharma , Small Pharma Share , Cybin Shares , Cboe Canada , Small Pharma Shares , Pharma Special ,

CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings

Adelia”) for up to CDN$20,161,575 (approximately USD$15.75 million) (the “
Transaction”).
Transaction Highlights
Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications. Selective modification, through deuteration of psychedelic parent molecules, allows control of the duration of action of these new chemical entities, enabling the design of both short and long-acting treatments.
Adelia brings a range of technologies related to novel therapeutics, delivery methods, and therapeutic regimens, as well as six patent applications.
Adelia contributes an expanding library of psychedelic derivative drug development candidates. The first lead compounds are expected to enter clinical studies in 2021, subject to receipt of approvals. ....

United States , Northeastern University , Brett Greene , Michaelg Palfreyman , Michael Palfreyman , Doug Drysdale , Alex Nivorozhkin , Eli Lilly , Brettj Greene , Development Officer , Cybin Corp , Nova Capital International , Cybin Inc , Drug Administration , Cybin Us Holdings Inc , Health Canada , Chief Executive Officer , Chief Strategy Officer , Drug Discovery , Chief Operating Officer , Chief Scientific , Chief Research , Chief Innovation , Adelia Shareholders , Classb Share , Classb Shares ,